Diligence memo · auto-generated · as of July 2, 2026
Artisan Pharma, Inc.
Artisan Pharma, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Artisan Pharma, Inc. operates in Biotechnology, based in WALTHAM.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Artisan Pharma, Inc. has raised $50M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $22M on 2010-02-25.
Most recent recorded round closed around 2010-07-14.
Valuation (modeled)modeled
Provath models Artisan Pharma, Inc. at approximately $119M (range $6.0M–$458M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.18× the median modeled value of Series B Biotechnology companies in 2010–2012 (48 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 16.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 7.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 82% of Biotechnology peers (4293 compared).
Modeled value ranks above 62% of those peers.
Closest niche peers: Redpoint Bio CORP, Cardiaq Valve Technologies Inc, Visterra, Inc., Celltex Therapeutics Corp, Crown Bioscience, Inc.
Peoplefiled
19 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.